Similarly, Riches et al. found that the ATM-selective small molecule inhibitor AZD0156 enhanced the inhibitory effect of radiotherapy on tumor growth by eliminating radiotherapy-induced activation of the ATM signaling pathway, in both the NSCLC cell line xenograft model and the PDX model (Riches et al., 2020). Here, ATM is linked to neoplasm.